The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
Abstract There has been a global increase in the use of cannabinoids as a treatment for mental health (MH) and substance use disorders (SUD). In 2016, an Australian government-funded review found that although medicinal cannabinoids accounted for a small reduction in MH symptoms, the results varied...
Saved in:
| Main Authors: | Jack Wilson, Andrew Langcake, Zachary Bryant, Tom P. Freeman, Janni Leung, Gary C. K. Chan, Amir Englund, Myfanwy Graham, Emily Stockings |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Systematic Reviews |
| Online Access: | https://doi.org/10.1186/s13643-024-02657-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders
by: Martine Skumlien, et al.
Published: (2025-06-01) -
Synthetic Cannabinoids Use among Inmates in an English Prison
by: S. Craft, et al.
Published: (2024-12-01) -
Cannabinoids on the Brain
by: Andrew J. Irving, et al.
Published: (2002-01-01) -
Pharmacokinetics of Cannabinoids
by: Iain J McGilveray
Published: (2005-01-01) -
The biosynthesis of the cannabinoids
by: M. Nazir Tahir, et al.
Published: (2021-03-01)